Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 11 entities : Ibio, inc. save search
GentiBio Nets $157 Million to Restore Immune Tolerance with Tregs
Published: 2021-08-11 (Crawled : 13:15) - biospace.com/
IBIO | $1.72 -2.83% 0.0% 95K
|
Health Technology
|
| O: 0.0%
H: 0.77%
C: -3.85%
GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat Autoinflammation
Published: 2021-08-11 (Crawled : 12:00) - biospace.com/
IBIO | $1.72 -2.83% 0.0% 95K
|
Health Technology
|
| O: 0.0%
H: 0.77%
C: -3.85%
potential t-cell
GentiBio Nets $157M to Restore Immune Tolerance With Tregs
Published: 2021-08-11 (Crawled : 11:00) - biospace.com/
IBIO | $1.72 -2.83% 0.0% 95K
|
Health Technology
|
| O: 0.0%
H: 0.77%
C: -3.85%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.